R
Revvity RVTY
$154.39
−1.67%
Nov 13
1W
1M
3M
6M
1Y
3Y
5Y
Key indicators
P/E
71
Usually: 51
Sales
+5%
$2.94B over 12 months
Net margin
9%
Low
High
Volatility
40%
Calm
Choppy
Bars: against the 32 close companies.
Key indicators
When a figure has a bar, the marker places it among its peers, and the further right it sits, the more the figure beats the others. Green marks the best third, red the weakest and white anything in between. Some figures stay white wherever they sit, like price, pace or holding time, because neither side is better there.
Earnings release
The day the company publishes its quarterly accounts: revenue, profit, and often its outlook. The price sometimes moves sharply that day, in either direction. Over the long term, what matters is the trend of profits from one quarter to the next, not the reaction of the day.
Posts
No posts about RVTY yet.
About Revvity, Inc.
Revvity sells instruments, chemicals and tests to drug and biotech researchers, diagnostic labs, hospitals and governments. Its Life Sciences unit supplies research tools, and its Diagnostics unit sells screening and testing products. Most revenue comes from selling these products and the supplies and services that go with them.